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Abstract The roles of long noncoding RNAs (lncRNAs) in musculoskeletal development, disease,
and regeneration remain poorly understood. Here, we identified the novel lncRNA GRASLND
(originally named RNF144A-AS1) as a regulator of mesenchymal stem cell (MSC) chondrogenesis.
GRASLND, a primate-specific lncRNA, is upregulated during MSC chondrogenesis and appears to
act directly downstream of SOX9, but not TGF-b3. We showed that the silencing of GRASLND
resulted in lower accumulation of cartilage-like extracellular matrix in a pellet assay, while
GRASLND overexpression – either via transgene ectopic expression or by endogenous activation
via CRISPR-dCas9-VP64 – significantly enhanced cartilage matrix production. GRASLND acts to
inhibit IFN-g by binding to EIF2AK2, and we further demonstrated that GRASLND exhibits a
protective effect in engineered cartilage against interferon type II. Our results indicate an
important role of GRASLND in regulating stem cell chondrogenesis, as well as its therapeutic
potential in the treatment of cartilage-related diseases, such as osteoarthritis.
Introduction
Articular cartilage is an aneural, avascular tissue and has little or no capacity for intrinsic repair
(Sophia Fox et al., 2009), and there are currently no effective procedures that result in long-term
cartilage restoration. Furthermore, focal cartilage or osteochondral lesions generally progress to
osteoarthritis (OA), a progressive degenerative disease characterized by changes in the articular car-
tilage and remodeling of other joint tissues such as the synovium and subchondral bone. Thus, there
remains an important need for regenerative therapies that can enhance cartilage repair through tis-
sue engineering or cell therapy approaches (Huynh et al., 2018a; Glass et al., 2014; Brunger et al.,
2017a; Brunger et al., 2017b; Brunger et al., 2014; Adkar et al., 2017; Bhumiratana et al., 2014).
In this regard, adult stem cells such as bone marrow-derived mesenchymal stem cells (MSCs) or
adipose-derived stem cells (ASCs) provide a readily accessible source of multipotent cells that show
significant promise for regenerative medicine (Gimble and Guilak, 2003; Erickson et al., 2002;
Awad et al., 2004; Caplan, 1991). Under defined culture conditions supplemented with Transform-
ing Growth Factor Beta 3 (TGF-b3), MSCs produce a cartilaginous matrix that is rich in glycosamino-
glycans (GAGs) and collagen type II (COL2) (Mackay et al., 1998; Johnstone et al., 1998).
However, the complete pathway involved in MSC chondrogenesis has not been fully deciphered. A
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detailed understanding of the gene regulatory networks that control this process could provide new
insights that accelerate and improve cartilage regeneration from endogenous stem cells or exoge-
nously implanted MSCs.
Increasing evidence suggests that the gene regulatory pathways involved in stem cell differentia-
tion may rely not only on protein-coding RNAs, but also on non-coding RNAs (ncRNAs). ncRNAs
were initially difficult to identify because they did not possess open reading frames and were
not evolutionarily highly conserved (Lander et al., 2001). In one of the first landmark studies, chro-
matin-state mapping was used to identify transcriptional units of functional large intervening non-
coding RNAs (lincRNAs) that were actively transcribed in regions flanking protein-coding loci
(Guttman et al., 2009), and follow-up loss-of-function studies indicated that these lincRNAs were
indeed crucial for the maintenance of pluripotency in embryonic stem cells (Guttman et al., 2011).
There is a growing understanding of long non-coding RNA (lncRNA) function in a multitude of tis-
sues and cellular processes. For example, detailed mechanistic studies on the role of lncRNAs in X
chromosome inactivation (Lee and Bartolomei, 2013) or in nervous system development and func-
tions (Ng et al., 2012; Briggs et al., 2015) have been reported previously. However, knowledge of
their roles in the musculoskeletal system, particularly in chondrogenesis, remains limited. Only a
handful of functional studies have been carried out in this regard. For example, lncRNA-HIT (HOXA
Transcript Induced by TGFb) (Carlson et al., 2015) has been shown to play a role in epigenetic regu-
lation during early limb development. Other studies have implicated a specific lncRNA, ROCR (Regu-
lator of Chondrogenesis RNA) (Barter et al., 2017) in activity upstream of SRY-Box 9 (SOX9) and in
the regulation of chondrocyte differentiation (Huynh et al., 2017).
As one of their many modes of actions, lncRNAs are also known to regulate and modulate various
signaling cascades involved in the control of gene regulatory networks. Therefore, there may exist a
connection between lncRNA candidates and signaling pathways previously known to play a role in
the development of the musculoskeletal system. More specifically, there is growing evidence for the
role of interferon (IFN) in skeletal tissue development and homeostasis (Dieudonne et al., 2013;
Rostovskaya et al., 2018; Takayanagi et al., 2002a; Takayanagi et al., 2002b; Li, 2013;
Sahni et al., 1999; Jang and Baik, 2013; Xiao et al., 2004; Sahni et al., 2001). There are two main
types of IFN. Type I IFN includes mainly IFN alpha (IFN-a) and IFN beta (IFN-b), which form com-
plexes with Interferon Alpha and Beta Receptors (IFNARs), activating the Janus Kinase/Signal Trans-
ducers and Activators of Transcription (JAK/STAT) pathway by phosphorylation of STAT1 (Signal
Transducer and Activator of Transcription 1) and STAT2 (Signal Transducer and Activator of Tran-
scription 2). Phosphorylated STAT1/STAT2 then form complexes with IRF9 (IFN Regulatory Factor 9)
and translocate into the nucleus to activate downstream targets via the interferon-stimulated respon-
sible element (ISRE) DNA-binding motif. Type II IFN, on the other hand, relies on activation of the
JAK/STAT pathway following the binding of IFN gamma (IFN-g) to Interferon Gamma Receptors
(IFNGRs). This process subsequently results in the phosphorylation and dimerization of STAT1, which
translocates into the nucleus and induces downstream targets via the gamma activated sequence
(GAS) DNA-binding element (Brierley and Fish, 2002; Hertzog et al., 1994; Hu and Ivashkiv,
2009). Although IFN are widely known for their antiviral response, they can also act in other aspects
of cellular regulation (Hertzog et al., 1994). Interestingly, IFN-g has been implicated in non-viral pro-
cesses, most notably due to its priming effect in auto-immune diseases such as lupus nephritis, multi-
ple sclerosis, or rheumatoid arthritis (Green et al., 2017). An additional goal of this study was to
elucidate the link between IFN-g and our lncRNA candidate, and how this interaction could poten-
tially play a role in MSC chondrogenesis and cartilage tissue engineering.
In a recent publication, we used high-depth RNA sequencing to map the transcriptomic trajectory
of MSC chondrogenesis (Huynh et al., 2018b). This dataset provides a unique opportunity to iden-
tify candidate genes for subsequent functional characterization as regulators of chondrogenesis.
Here, we used bioinformatic approaches to integrate our RNA-seq data with other publicly available
datasets, applying a rational and systematic data-mining method to define a manageable list of final
candidates for follow-up experiments. As a result, we identified RNF144A-AS1 as a crucial regulator
of chondrogenesis and propose the name Glycosaminoglycan Regulatory ASsociated Long Non-
coDing RNA (GRASLND). We showed that GRASLND enhances chondrogenesis by acting to sup-
press the IFN-g signaling pathway, and that this effect was prevalent across different adult stem cell
types and conditions. Together, these results highlight novel roles of GRASLND and its modulation
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of IFN in stem cell chondrogenesis, as well as its therapeutic potential to enhance cartilage
regeneration.
Results
GRASLND is crucial to and specifically upregulated in chondrogenesis
First, we utilized our published database on MSC chondrogenesis (GSE109503) (Huynh et al.,
2018b) to identify lncRNA candidates. We investigated the expression patterns of MSC markers
(ALCAM, ENG, VCAM1), chondrogenic markers (ACAN, COL2A1, COMP), and SOX transcription
factors (SOX5, SOX6, SOX9) (Figure 1—figure supplement 1A). Pearson correlation analysis
revealed 141 lncRNAs whose expression was highly correlated to those of MSC markers, 40 lncRNAs
to chondrogenic markers, and 17 lncRNAs to SOX transcription factors (Figure 1—figure supple-
ment 1B,C). Among those, LOXL1-AS1 and MIR4435-1HG were downregulated and RP11-366L20.2
and GRASLND were upregulated upon ectopic SOX9 overexpression (Table 1 and
Supplementary file 1) (GSE69110; Ohba et al., 2015). To validate the functions of these lncRNAs in
chondrogenesis, we systematically designed small hairpin RNAs (shRNAs) targeting each candidate
and assessed the knockdown effect after 21 days of chondrogenic induction. We successfully
designed two target shRNAs for LOXL1-AS1, MIR4435-1HG, and GRASLND, and one target shRNA
for RP11-366L20.2 (Figure 1B, Figure 1—figure supplement 2A–C, Figure 1—source data 1). We
showed that knockdown of two out of three MSC-related lncRNAs did not influence the production
of glycosaminoglycans (GAG), an important extracellular matrix component in cartilage (Figure 1—
figure supplement 2A–C). Although these lncRNAs may have other regulatory functions in MSCs,
their roles in chondrogenesis appeared to be minimal. Moreover, we found that lower levels of
MSC-correlated lncRNAs did not prime the MSCs toward chondrogenesis. However, knockdown of
GRASLND (alias RNF144A-AS1 [RNF144A Antisense RNA 1]) resulted in decreased expression of
chondrogenic markers (COL2A1, ACAN) and in upregulation of apoptotic (CASP3) and cellular
senescence (TP53) markers (Figure 1A,B). This effect was not due to nonspecific cytotoxicity of
the examined shRNAs, as released levels of lactase dehydrogenase (LDH) were similar among con-
trol and shRNA-expressing cells (Figure 1—figure supplement 2D; Riss et al., 2004). In addition,
biochemical assays indicated a reduction in both GAG deposition (p<0.0001) and DNA and GAG/
DNA levels (p<0.001) (Figure 1C–E). Histologically, we observed the same phenotypic loss of GAG
and collagen type II in the extracellular matrices (ECM) of pellet samples with GRASLND targeted
shRNAs, while the scrambled controls displayed explicit staining of these proteins (Figure 1F). Taken
together, these data indicate that GRASLND may be required for both cellular proliferation and car-
tilage-like matrix production.
To establish whether GRASLND expression is specific to chondrogenesis or involved in other dif-
ferentiation pathways, MSCs were induced towards adipogenic, osteogenic, or chondrogenic line-
ages, and GRASLND expression was measured at various timepoints throughout these processes.
Successful differentiation was observed with an increase in lineage-specific markers: PPARG
Table 1. Long non-coding RNA candidates shortlist.
Gene symbol Gene name ENSEMBL gene ID
Relationship to
MSC chondrogenesis Relationship to SOX9
LOXL1-AS1 LOXL1 antisense RNA 1 ENSG00000261801 Correlated with MSC
marker expression
Downregulated
upon SOX9
overexpression
MIR4435-2HG
gene synonym:
MIR4435-1HG
MIR4435-2 host gene ENSG00000172965 Correlated with MSC
marker expression
Downregulated
upon SOX9
overexpression
HMGA2-AS1
gene synonym:
RP11-366L20.2
HMGA2 antisense RNA 1 ENSG00000197301 Correlated with MSC
marker expression
Upregulated upon
SOX9 overexpression
RNF144A-AS1
Referred to as
GRASLND in this manuscript
RNF144A antisense RNA 1 ENSG00000228203 Correlated with
chondrogenic
marker expression
Upregulated upon
SOX9 overexpression
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(Peroxisome Proliferator Activated Receptor Gamma) and ADIPOQ (Adiponectin, C1Q And Colla-
gen Domain Containing) for adipogenesis, COL1A1 (Collagen Type I Alpha 1 Chain) and COL10A1
(Collagen Type X Alpha Chain 1) for osteogenesis, and ACAN (Aggrecan), SOX9 (SRY-Box 9) and
COL2A1 (Collagen Type II Alpha Chain 1) for chondrogenesis (Figure 1G–I). We found that
GRASLND expression was particularly enriched as chondrogenesis progressed (Figure 1I). By con-
trast, GRASLND peaked at earlier timepoints during adipogenesis but decreased at later time points
Figure 1. GRASLND is important and specifically upregulated in MSC chondrogenesis. (A) Expression pattern of GRASLND in chondrogenesis
(GSE109503; Huynh et al., 2018b). Log2TPM: log transformed value of transcripts per million (TPM). (B) Effect of GRASLND knockdown on
chondrogenic, apoptotic, and cell-cycle-inhibition markers (n = 5). (C–E) Effect of GRASLND knockdown on pellet matrix synthesis (n = 5). (F)
Representative histological images of day 21 MSC pellets. Scale bar = 200 mm. SafO-FG, SafraninO-Fast Green staining; COLII IHC, collagen type II
immunohistochemistry; hOC, human osteochondral control. (G–I) qRT-PCR analysis of MSC samples cultured in (G) the adipogenic condition (n = 6), (H)
the osteogenic condition (n = 6), and (I) the chondrogenic condition (n = 3–4). One-way ANOVA followed by Tukey post-hoc test (a = 0.05). Groups of
different letters are statistically different from one another.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. shRNA target sequences (50 – sequence – 30).
Source data 2. qRT-PCR sequencing primers (50 – sequence – 30).
Figure supplement 1. Identification of lncRNA candidates.
Figure supplement 2. Functional validation of identified lncRNA candidates.
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(Figure 1G), and downregulated when MSCs underwent osteogenic induction (Figure 1H), indicat-
ing that GRASLND is specifically upregulated in chondrogenesis. Furthermore, we speculate that
GRASLND may display inhibitory effects on osteogenesis and adipogenesis, being downregulated
during these processes.
To validate these gene expression findings, we performed RNA fluorescence in situ hybridization
(FISH) throughout the time course of MSC chondrogenesis. Pellets exhibited GRASLND FISH signals
at later time points during chondrogenic differentiation, consistent with the RNA-seq data
(Figure 2A). Next, to confirm the subcellular location of GRASLND, we performed qRT-PCR on iso-
lated nuclear and cytoplasmic fractions of day 21 MSC pellets (Figure 2B). We compared the subcel-
lular expression patterns of GRASLND to those of NEAT1 (Nuclear Paraspeckle Assembly Transcript
1) and GAPDH (Glyceraldehyde 3-Phosphate Dehydrogenase). NEAT1 is a lncRNA previously charac-
terized as localizing at the nucleus (Clemson et al., 2009; Sasaki et al., 2009), and GAPDH is an
mRNA and thus should be exported to the cytoplasm for protein synthesis. Consistent with previous
findings, NEAT1 displayed lower expression in the cytoplasmic fraction compared to the nuclear
fraction, in contrast to GAPDH. GRASLND exhibited higher expression in the cytoplasm, indicating a
cytoplasmic subcellular location. Our finding was recapitulated by RNA in situ hybridization followed
by confocal microscopy (Figure 2C). Interestingly, as GRASLND showed punctate labeling, we spec-
ulate that this lncRNA may function in the form of an RNA–protein complex.
Characterization of GRASLND
We examined the characteristics of GRASLND by first exploring its evolutionary conservation. Except
for exon 1, the genomic region of GRASLND (displayed as RNF144A-AS1 in the UCSC Genome
Browser) is highly conserved in primates (Homo sapiens, Pan troglodytes, and Rhesus macaque)
whose common ancestor can be traced back to 25 million years ago (Gibbs et al., 2007), while
sequences are less conserved in other mammals (Figure 3A). This suggests that GRASLND may
belong to a group of previously identified primate-specific lncRNAs (Derrien et al., 2012;
Necsulea et al., 2014).
Per GENCODE categorization, the AS (antisense) suffix indicates a group of lncRNAs that are
positioned on the opposite strand, with overlapping sequences to their juxtaposed protein-coding
genes. Often, these lncRNAs play a role in regulating the expression of their protein-coding counter-
parts (Huynh et al., 2017). Therefore, we set out to examine whether this is also the case for
GRASLND (alias RNF144A-AS1) (Figure 3B–C). Neither knockdown nor overexpression of GRASLND
affected RNF144A transcript levels in MSCs cultured with or without TGF-b3. Moreover, RNF144A
protein levels also remained unaffected by variations of GRASLND levels, as indicated by western
blot (Figure 3D and Figure 3—figure supplement 1). These results indicate that GRASLND is not
involved in the regulation of RNF144A. For these reasons, we proposed that GRASLND should be
used to refer to the lncRNA in place of RNF144A-AS1.
Next, we explored the signaling axis of GRASLND. Data mining and computational analysis on
earlier published data suggested that GRASLND was a downstream effector of SOX9 (GSE69110)
(Ohba et al., 2015). When SOX9 was overexpressed in fibroblasts, GRASLND expression was
increased (~2 fold). We further confirmed this by utilizing SOX9 transgene overexpression in our
MSCs culture (Figure 3E). Interestingly, although TGF-b3 has been demonstrated to act upstream of
SOX9, exogenous addition of this growth factor alone did not result in enhanced GRASLND expres-
sion. It is notable that SOX9 levels in GFP controls were indistinguishable between TGF-b3 condi-
tions at the time of investigation (1 week in monolayer culture), consistent with our previous finding
that SOX9 was not upregulated until later timepoints in MSC chondrogenesis (Huynh et al., 2018b).
Therefore, TGF-b3, despite being a potent growth factor, is not sufficient to elevate GRASLND
expression. Instead, GRASLND appeared to be a downstream target of SOX9.
Enhanced chondrogenesis for cartilage tissue engineering with
GRASLND
As knockdown of GRASLND inhibited GAG and collagen deposition, we investigated whether over-
expression of GRASLND would enhance chondrogenesis. We assessed this question by both trans-
gene ectopic expression and by CRISPR-dCas9 (Clustered regularly interspaced short palindromic
repeats – catalytically dead Cas9) mediated in-locus activation.
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Figure 2. GRASLND is localized to the cytoplasm. (A) RNA in situ hybridization of MSC-derived pellets at different
time points during chondrogenesis. GAPDH and GRASLND probes were hybridized on separate slides. Top three
panels, scale bar = 20 mm; bottom panel, scale bar = 10 mm. (B) qRT-PCR of the nuclear versus cytoplasmic
fraction of day 21 MSC pellets (n = 4). NEAT1, Nuclear Paraspeckle Assembly Transcript 1. One-way ANOVA
Figure 2 continued on next page
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We designed our lentiviral transfer vector to carry a BGH-pA (Bovine Growth Hormone Polyade-
nylation) termination signal downstream of GRASLND to allow for its correct processing (Figure 4—
figure supplement 1A). In addition, GRASLND was also driven under a doxycycline-inducible pro-
moter, enabling the temporal control of its expression. We utilized this feature to induce GRASLND
only during chondrogenic culture (Figure 4A). This experimental design focused solely on the role of
Figure 2 continued
followed by Tukey post-hoc test (a = 0.05) was used. Groups of different letters are statistically different from one
another. (C) Confocal microscopy on MSC-derived pellets. Scale bar = 5 mm.
The online version of this article includes the following source data for figure 2:
Source data 1. Cloning primer sequences (50 – sequence – 30).
Source data 2. GRASLND probe set sequences (50 – sequence – 30).
Figure 3. GRASLND relationship to RNF144A and SOX9. (A) GRASLND genomic location and conservation across
different species. Data were retrieved from UCSC Genome Browser. (B) Knockdown of GRASLND and expression
of RNF144A (n = 4). (C) Overexpression GRASLND and expression of RNF144A (n = 4). Welch’s t-test. (D) Protein
amount of RNF144A by western blot in variation of GRASLND levels. Lanes indicate biological replicates. Full
bands are shown in Figure 3—figure supplement 1. (E) GRASLND level in GFP- or SOX9-transduced MSCs under
different doses of TGF-b3 (n = 6). Two-way ANOVA followed by Tukey post-hoc test (a = 0.05) was carried out on
the effect of SOX9 overexpression (p<0.0001) and doses of TGF-b3 (p>0.05). The interaction between two tested
factors (SOX9 overexpression and TGF-b3 doses) was not significant (p>0.05). Groups of different letters are
statistically different. ns, not significant.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Full bands of western blot from Figure 3D.
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GRASLND during chondrogenesis, while successfully eliminating its effect in MSC maintenance and
expansion from our analysis. As control, a vector encoding the Discosoma sp. red fluorescent protein
(dsRed) coding sequence in place of GRASLND was utilized. As doxycycline was most potent at 1
mg/mL (Figure 4—figure supplement 1B,C), this dose was used for all of the following experiments.
To determine whether GRASLND would improve chondrogenesis at lower doses of growth factor
or at earlier time points, we compared DNA and GAG levels from pellets cultured under different
TGF-b3 concentrations on day 7, day 14, and day 21 (Figure 4—figure supplement 1D–F). In agree-
ment with our knockdown data, DNA content was unaffected. On the other hand, increases in GAG
Figure 4. GRASLND enhances chondrogenesis. (A) Experimental timeline. (B, C) Biochemical analyses of day 21
MSC pellets (n = 4). Welch’s t-test. (D, E) qRT-PCR analyses of day 21 MSC pellets (n = 5 in panel [D]; n = 6 in
panel [E]). Welch’s t-test. (F) Representative histological images of day 21 MSC pellets. COLII IHC, collagen type II
immunohistochemistry; hOC, human osteochondral control. Scale bar = 100 mm. (B, D, F) Transgene ectopic
expression of GRASLND. (C, E, F) CRISPR-dCas9-VP64-induced activation of GRASLND. ns, not significant
(p>0.05).
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. Effect of GRASLND overexpression across time points and tested doses.
Figure supplement 2. Synthetic guide RNA screening for efficient activation of endogenous GRASLND.
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were observed at higher doses and at later time points, especially at 10 ng/mL of TGF-b3. It appears
that an elevated level of GRASLND alone was not sufficient to enhance GAG deposition when lower
levels of TGF-b3 were used (0.1 ng/mL and 1 ng/mL) or at earlier time points (day 7 and day 14),
and that GRASLND may act in concert with other downstream effectors, which were not present at
lower doses of TGF-b3 or at earlier time points in the process.
When chondrogenesis was induced with 10 ng/mL of TGF-b3 and assessed at 21 days post induc-
tion, overexpression of GRASLND resulted in higher amounts of GAG deposition (p<0.001)
(Figure 4B), consistent with our data on the gene expression level (Figure 4D). We observed a slight
increase in chondrogenic markers (COL2A1, ACAN), and a slight decrease in the apoptotic marker
CASP3, whereas cellular senescence was not different between the two groups (TP53) (Figure 4D).
Histologically, pellets derived from dsRed-transduced MSCs exhibited normal GAG and collagen
type II staining, indicating successful chondrogenesis. The control pellets were indistinguishable
from those derived from GRASLND-transduced MSCs (Figure 4F), albeit macroscopically smaller at
the time of harvest.
These findings were further confirmed using CRISPR-dCas9-VP64-mediated activation of endoge-
nous GRASLND. This system had been previously utilized to upregulate various transcription factors
that efficiently induce embryonic fibroblasts into neurons (Black et al., 2016; Perez-Pinera et al.,
2013). After screening eleven synthetic gRNAs, we selected the one with the highest activation level
(Figure 4—figure supplement 2). When GRASLND was transcriptionally activated with CRISPR-
dCas9, chondrogenesis was enhanced as evidenced by an elevated amount of GAG deposition
(p<0.01); DNA amount may also be slightly increased, albeit not to a statistically significant level
(Figure 4C). Similar trends were detected by qRT-PCR (Figure 4E) and histology (Figure 4F). It is
worth noting that CRISPR-dCas9-mediated activation only resulted in a moderate upregulation of
GRASLND expression relative to transgene ectopic expression (2-fold vs 100-fold). However, the
functional outcome was more pronounced with CRISPR-dCas9. We observed an approximately 50%
increase in the level of GAG produced when normalized to DNA (9.4 ± 2.19 mg/mg vs 16.3 ± 2.08
mg/mg), compared to 30% detected with ectopic expression (10.5 ± 0.84 mg/mg vs 13.9 ± 0.52 mg/
mg).
GRASLND inhibits type II interferon signaling potentially by binding to
EIF2AK2 and protects engineered cartilage from interferon
To decipher the potential signaling pathways involved, we chondrogenically induced MSCs in the
presence or absence of GRASLND, and then utilized RNA-seq to compare the global transcriptomic
changes between two conditions. As expected, GRASLND depletion resulted in impaired expression
of chondrocyte-associated genes such as TRPV4 and COL9A2 (top 20 downregulated genes ranked
by adjusted p-values) (Figure 5A). Skeletal system development and extracellular matrix organiza-
tion were among the pathways most affected by the knockdown (Figure 5B). Surprisingly, pathways
pertaining to interferon response were highly enriched in the upregulated gene list upon silencing of
GRASLND. The top 20 upregulated genes involved many IFN downstream targets (MX2, IFI44,
IFI44L, IFITM1, IFI6, IFIT1, STAT1, MX1, IFIT3, OAS3, OAS2), with both type I (IFN-a, IFN-b) and
type II (IFN-g) found to be enriched in our gene ontology analysis (Figure 5B). Furthermore, upregu-
lated genes were also found to exhibit DNA-binding motifs for transcription factors of the IFN path-
ways: STAT1, STAT2, IRF1, and IRF2 (Table 2). A full list of differentially expressed genes is provided
in Supplementary file 2. Further bioinformatic analyses created a network of potential transcription
regulators as well as gene ontology terms for the upregulated gene cohort as a result of GRASLND
silencing (Figure 5C). Taken together, GRASLND may act to suppress the activities of these tran-
scription factors, and as a result could affect IFN signaling pathways during chondrogenesis.
To further confirm this relationship, we performed luciferase reporter assays for interferon signal-
ing upon GRASLND knockdown. Utilizing specific reporter constructs, we were able to determine
whether GRASLND acted on type I or type II IFN. Our results indicated that a decreased level of
GRASLND led to a heightened type II (IFN-g ) (Figure 5E) response but not to a heightened type I
(IFN-b) response (Figure 5D). Importantly, luminescence activities between scrambled control and
GRASLND knockdown were indistinguishable from each other in basal, IFN-free conditions. This indi-
cates that at the basal level, the two groups responded similarly to lentiviral transduction, and
that the observed difference in IFN signal was a consequence of GRASLND downregulation.
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Figure 5. GRASLND suppresses interferon type II signaling. (A) Top 20 up- and down-regulated genes in
GRASLND KD pellets compared to scrambled controls. (B) Gene ontology analysis of affected pathways. (C)
Upregulated targets and related gene ontology terms and potential transcription factors. (D,E) Luciferase reporter
assays on MSCs transduced with: (D) ISRE promoter element (n = 3), or (E) GAS promoter element (n = 3). Two-
way ANOVA followed by Tukey post-hoc test (a = 0.05). Groups of different letters are statistically different. (F)
RNA pull-down followed by western blot (full bands are shown in Figure 5—figure supplement 2). (G) RNA
immunoprecipitation confirmed EIF2AK2 as the binding partner of GRASLND (n = 2). (H) Biochemical assays on
MSC-derived pellets cultured under 100 ng/mL of IFN-b (n = 4). (I) Biochemical assays on MSC-derived pellets
cultured under 5 ng/mL of IFN-g (n = 6). Welch’s t-test. ns, not significant.
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. Relationship between GRASLND and IFN.
Figure supplement 2. Full bands of RNA pull-down followed by western blot.
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Since GRASLND was expressed in the cytoplasm (Figure 2C), we hypothesized that it is part of
an RNA–protein complex. To test this, we performed an RNA pull-down assay, followed by mass
spectrometry. Here, streptavidin beads were used as control, or conjugated to sense or antisense
strands of GRASLND. Naked or conjugated beads were then incubated with lysates from day 21 pel-
lets, from which bound proteins were eluted for further analyses. We found that Interferon-Induced
Double-Stranded RNA-Activated Protein Kinase (EIF2AK2) peptides were detected at elevated levels
in sense samples as compared to antisense controls (p<0.05); peptides were undetected in naked
bead controls. Subsequent RNA pull-down followed by western blot confirmed EIF2AK2 as a binding
partner of GRASLND (Figure 5F). We detected an increased level of EIF2AK2 bound to the sense
strand of GRASLND relative to the antisense strand or the pellet lysate control. Similarly, GRASLND
was found to be associated with endogenous EIF2AK2 by RNA immunoprecipitation (RIP)
(Figure 5G). On the basis of these findings, we speculate that this association of GRASLND RNA to
EIF2AK2 could potentially result in downregulation of IFN-g signaling.
Interestingly, by mining a published microarray database (GSE57218) (Ramos et al., 2014), we
found that IFN-related genes (STAT1, IFNGR2, NCAM1, MID1) were highly elevated in the cartilage
tissues of osteoarthritis patients (Figure 5—figure supplement 1A). As the microarray did not con-
tain probes for GRASLND, no information on its expression could be extracted. In addition, we iden-
tified another independent study that reported changes in the transcriptomes of intact and
damaged cartilage tissues (E-MTAB-4304) (Dunn et al., 2016). Similarly, a cohort of IFN-related
genes was also upregulated in damaged cartilage, especially STAT1 and IFNGR1 (Figure 5—figure
supplement 1B). Interestingly, we identified a negative correlation between GRASLND and a few
IFN related genes (IFNGR1, ICAM1) in damaged cartilage (Figure 5—figure supplement 1C).
Therefore, we proposed that GRASLND may possess some therapeutic potential through suppres-
sion of IFN signaling in osteoarthritis. To evaluate this possibility, we implemented the use of the
GRASLND transgene in engineered cartilage cultured under IFN addition (100 ng/mL of IFN-b or 5
ng/mL of IFN-g). We determined doses of IFN-b and IFN-g by selecting the lowest concentration at
which day 21 pellets exhibited GAG loss when compared to no IFN control. Consistent with lucifer-
ase reporter assays, the protective effect of GRASLND was observed upon IFN-g challenge but not
upon IFN-b challenge (Figure 5H,I). However, we observed a reduced level of GAG production com-
pared to normal conditions, suggesting that GRASLND can protect the ECM from degradation, but
not completely to control levels.
Table 2. Top 5 enriched Cis-BP motifs and associated transcription factors for upregulated genes upon GRASLND knockdown.
Transcription factor Cis-BP motif* Number of genes with enriched motifs/number of upregulated genes
STAT2 212/817
IRF2 189/817
IRF1 220/817
IRF1 153/817
STAT1 262/817
*Cis-BP: Catalogue of Inferred Sequence Preferences of DNA-Binding Proteins (Weirauch et al., 2014). Curated position weight matrices were retrieved
from http://motifcollections.aertslab.org.
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GRASLND enhanced the chondrogenesis of adipose-derived stem cells
To determine whether the function of GRASLND is unique to MSCs or present in other adult stem
cells, we addressed whether modulating GRASLND expression could also improve chondrogenesis
of adipose stem cells (ASCs). We observed an increase in GAG production when GRASLND was
overexpressed in ASCs compared to control (p<0.0001) (Figure 6A), although ACAN levels were
not significantly increased. Importantly, COL2A1 expression was significantly elevated (~5 fold) with
overexpression of GRASLND (Figure 6B). On the basis of these data, it appears that GRASLND uses
the same mechanism across these two cell types, asserting a pan effect on potentiating their chon-
drogenic capabilities. It is worth noting that histologic examination of the engineered cartilage
Figure 6. GRASLND enhances chondrogenesis in adipose-derived stem cells. (A) Biochemical analyses (n = 5). (B)
qRT-PCR analyses (n = 6). (C) Representative histological images of day 21 ASC pellets. COLII IHC, Collagen type
II immunohistochemistry; hOC, Human osteochondral control. Scale bar = 100 mm. Welch’s t-test. ns, not
significant.
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showed a similar level of collagen type II in pellets with GRASLND overexpression compared to the
dsRed control (Figure 6C), suggesting that the influence of GRASLND could be variable in different
target cells.
Discussion
Here, we identified and demonstrated the first functional study of lncRNA GRASLND, which acts to
enhance stem cell chondrogenesis. Knockdown of GRASLND via shRNA inhibited chondrogenesis,
whereas ectopic transgene or CRISPR-based overexpression of GRASLND enhanced chondrogenesis
of MSCs and ASCs. Pathway analysis revealed a link between GRASLND and the IFN-g signaling
pathway in this process, which was confirmed by the identification of EIF2AK2 as a
GRASLND binding partner. Unfortunately, lack of a known murine homolog makes it difficult to
study GRASLND in vivo, and thus future studies may require GRASLND transgenic models in primate
species.
In the context of the musculoskeletal system, IFN is mostly recognized for its role in bone devel-
opment and homeostasis (Dieudonne et al., 2013; Rostovskaya et al., 2018; Takayanagi et al.,
2002a; Takayanagi et al., 2002b; Li, 2013; Xiao et al., 2004) and myogenesis (Jang and Baik,
2013; Cheng et al., 2008; Londhe and Davie, 2011), as well as for its crosstalk with TGF-b in wound
healing (Ishida et al., 2004). Notably, IFN-g has been suggested to inhibit collagen synthesis in der-
mal fibroblasts, myofibroblasts, and articular chondrocytes (Ishida et al., 2004; Yufit et al., 1995;
Harrop et al., 1995; Granstein et al., 1990; Amento et al., 1985). Furthermore, the JAK/STAT
pathway, which involves IFN downstream effectors, has also been shown to inhibit chondrocyte pro-
liferation and differentiation (Sahni et al., 1999; Sahni et al., 2001). Here, we found that GRASLND
acts to suppress the IFN mechanism. In addition, we also present evidence that indicates an interac-
tion between GRASLND and EIF2AK2 (also referred to as PKR). Canonically, a crucial player in pro-
tein synthesis, EIF2AK2, has also been reported to control STAT signaling by directly binding to and
preventing its association with DNA for gene activation (Wang et al., 2006; Wong et al., 1997).
In addition, several studies have suggested that highly structured, single-stranded RNA can also acti-
vate PKR EIF2AK2 via its double-stranded RNA-binding domains (dsDRBs) (Osman et al., 1999;
Ben-Asouli et al., 2002; Cohen-Chalamish et al., 2009; Nallagatla et al., 2007; Mayo and Cole,
2017). Our RNA-seq data suggested that upon GRASLND knockdown, a cohort of downstream tar-
gets of STATs were upregulated. On the basis of the presence of DNA-binding motifs in the investi-
gated targets, we identified both STAT1 and STAT2 as potential regulators of genes
that are disrupted by GRASLND knockdown. However, our luciferase reporter assays pointed
towards a mechanism in IFN type II (gene activation by STAT1 homodimer) pathways rather than
type I (gene activation by STAT1/STAT2 heterodimer) pathways. Thus, we hypothesized that
GRASLND could form a secondary structure to bind and activate EIF2AK2, which in turn inhibits
STAT1-related transcriptional function. This mechanism supports the hypothesis that modulation of
IFN-g via the JAK/STAT pathway, achieved by the GRASLND–EIF2AK2 RNA–protein complex, is
important for cellular proliferation and differentiation during chondrogenesis.
Upregulation of IFN has also been implicated in arthritis by several studies (Boissier et al., 1995;
Cooper et al., 1988; Westacott et al., 1990; Kahle et al., 1992). Publicly available databases pro-
vide evidence corroborating similar patterns of IFN in degenerated cartilage (Ramos et al., 2014).
As GRASLND inhibits IFN, utilization of this lncRNA offers potential in both MSC cartilage tissue
engineering and OA treatment. As a proof of concept, we showed that GRASLND could enhance
matrix deposition across cell types of origin, with and without interferon challenge in vitro. Future
studies may wish to investigate whether GRASLND can protect cartilage from degradation in a
milieu of pro-inflammatory cytokines in vivo.
Since lentivirus was used to manipulate the expression of GRASLND, it is possible that our obser-
vations were confounded by the cellular response to viral infection. However, our luciferase reporter
assays demonstrated that basal luminescence levels (with no interferon supplementation) in the
scrambled controls and the shRNA treatments were indistinguishable. This finding suggests that
altered levels of interferon signaling can be attributed to experimentally varied levels of GRASLND
and not to the presence of lentivirus. Our data indicate that GRASLND acts through type II rather
than type I IFN. We found that 5 ng/mL of IFN-g was still more detrimental to chondrogenic con-
structs than 100 ng/mL of IFN-b. One potential explanation for this phenomenon may be the skewed
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distribution of available surface receptors between type I and type II IFN (IFNAR vs IFNGR). Indeed,
MSCs express a much lower level of IFNAR2 than of IFNAR1, IFNGR1, or IFNGR2 (both in
GSE109503 [Huynh et al., 2018b] and in GSE129985 [this manuscript]). As these receptors function
as heterodimers (Brierley and Fish, 2002; Hu and Ivashkiv, 2009), response to type I may be
stunted due to IFNAR2 deficiency.
Furthermore, we showed that a modified CRISPR-dCas9 system could be used successfully for
endogenous transcriptional activation of lncRNA. This system had been previously used in other cell
types to regulate the expression of both protein-coding and non-coding genes (Black et al., 2016;
Perez-Pinera et al., 2013; Bester et al., 2018; Liu et al., 2017). We showed that CRISPR may be
more effective than transgene expression, as indicated by a larger increase in GAG production,
despite lower levels of overall gene activation. As GRASLND does not regulate RNF144A, it is evi-
dent that GRASLND acts in trans. However, we speculate that the CRISPR-dCas9 system could also
be useful for gain-of-function studies to investigate lncRNAs acting in cis, as well as for studies of
lncRNAs that are difficult to obtain via molecular cloning because of their secondary structures,
highly repeated sequence or GC-rich content.
In conclusion, we have identified GRASLND as an important regulator of MSC chondrogenesis.
GRASLND acts downstream of SOX9 and enhances cartilage-like matrix deposition in stem cell-
derived constructs. Moreover, GRASLND functions to suppress IFN via EIF2AK2, and as a result
induces adult stem cells towards a more chondrocyte-like lineage. It is likely that the GRASLND–
EIF2AK2 RNA–protein complex inhibits STAT1 transcriptional activity. These findings suggest that
GRASLND has potential utility in enhancing stem cell chondrogenesis for therapeutic applications
such as cartilage tissue engineering or for the treatment of OA.
Materials and methods
Cell culture
Bone marrow was obtained from discarded and de-identified waste tissue from adult bone marrow
transplant donors in accordance with the Institutional Review Board of Duke University Medical Cen-
ter. Adherent cells were expanded and maintained in expansion medium: DMEM-low glucose
(Gibco), 1% penicillin/streptomycin (Gibco), 10% fetal bovine serum (FBS) (ThermoFisher), and 1 ng/
mL basic fibroblast growth factor (Roche) (Hagmann et al., 2013).
Adipose-derived stem cells (ASCs) were purchased from ATCC (SCRC-4000) and cultured in com-
plete growth medium: mesenchymal stem cells basal medium (ATCC PCS-500–030), mesenchymal
stem cell growth kit (ATCC PCS-500–040) (2% FBS, 5 ng/mL basic recombinant human FGF, 5 ng/mL
acidic recombinant human FGF, 5 ng/mL recombinant human EGF, 2.4 nM L-alanyl-L-glutamine),
and 0.2 mg/mL G418.
Plasmid construction
shRNA
Short hairpin RNA (shRNA) sequences for specific genes of interest were designed with the Broad
Institute GPP Web Portal (Moffat et al., 2006). For each gene, six different sequences were selected
for screening, after which the two most effective were chosen for downstream experiments in chon-
drogenic assays. Selected shRNAs were cloned into a modified lentiviral vector (Addgene #12247)
using MluI and ClaI restriction sites, as described previously (Diekman et al., 2015). A complete list
of effective shRNA sequences is presented in Figure 1—source data 1.
Transgene overexpression of GRASLND
A derivative vector from modified TMPrtTA (Glass et al., 2014; Barde et al., 2006) was created
with NEBuilder HiFi DNA Assembly Master Mix (New England Biolabs). Backbone was digested with
EcoRV-HF (New England Biolabs) and PspXI (New England Biolabs). The following resultant frag-
ments were amplified by polymerase chain reaction and assembled into the digested plasmid: Tetra-
cycline-responsive element and minimal CMV promoter (TRE/CMV), firefly luciferase, bGH poly(A)
termination signal (BGHpA). Primers and plasmids for cloning are provided in Figure 2—source
data 1.
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The full sequence of GRASLND transcript variant 1 (RefSeq NR_033997.1) was synthesized by
Integrated DNA Technologies, Inc. GRASLND or the Discosoma sp. red fluorescent protein coding
sequence (dsRed) were cloned into the above derivative tetracycline-inducible plasmid with NEBu-
ilder HiFi DNA Assembly Master Mix (New England Biolabs) at NheI and MluI restriction sites (pLVD-
GRASLND and pLVD-dsRed). Amplifying primers are listed in Figure 2—source data 1.
CRISPR-dCas9 activation of GRASLND
Guide RNA sequences were designed using the UCSC genome browser (http://genome.ucsc.edu/)
(Kent et al., 2002), integrated with the MIT specificity score calculated by CRISPOR and the Doench
efficiency score (Doench et al., 2016; Haeussler et al., 2016). Oligonucleotides (Integrated DNA
Technologies, Inc) were phosphorylated, annealed, and ligated into the pLV-hUbC-dCas9-VP64 lenti-
viral transfer vector (Addgene #53192) previously digested at BsmBI restriction sites (Kabadi et al.,
2014). Eleven potential guide RNA sequences were selected and screened for their efficacy, and the
gRNA with the highest activation potential was chosen for further experiments (Figure 4—figure
supplement 2). The synthetic gRNA used in all CRISPR-dCas9 activation experiments has the follow-
ing sequence: 50-CCACTGGGGATAGTTCCCTG-30.
Lentivirus production
HEK 293T producer cells were maintained in 293T medium: DMEM-high glucose (Gibco), 10% heat
inactivated FBS (Atlas), and 1% penicillin/streptomycin (Gibco). To produce lentivirus for pellet stud-
ies, HEK 293T cells were plated at 3.8  106 cells per 10 cm dish (Corning) or at 8.3  106 cells per
15 cm dish (Falcon) in 293T medium. The following day, cells were co-transfected by calcium phos-
phate precipitation with the appropriate transfer vector (20 mg for 10 cm dish; 60 mg for 15 cm dish),
the second-generation packaging plasmid psPAX2 (Addgene #12260) (15 mg for 10 cm dish; 45 mg
for 15 cm dish), and the envelope plasmid pMD2.g (Addgene #12259) (6 mg for 10 cm dish; 18 mg
for 15 cm dish). Cells were incubated at 37˚C overnight. The following day, fresh medium consisting
of DMEM-high glucose (Gibco), 10% heat-inactivated FBS (Atlas), 1% penicillin/streptomycin (Gibco),
and 4 mM caffeine (Sigma-Aldrich) was exchanged (12 mL for 10 cm dish; 36 mL for 15 cm dish).
Lentivirus was harvested 24 hr post medium change (harvest 1), when fresh medium was exchanged
again. 48 hr post medium change, harvest two was collected. Harvest one and harvest two superna-
tants were pooled, filtered through 0.45 mm cellulose acetate filters (Corning), concentrated, ali-
quoted, and stored at  80˚C for future use.
To produce lentivirus for shRNA and gRNA screening, HEK 293T cells were plated at 1.5–2  106
cells per well in a 6-well plate in DMEM-high glucose (Gibco), and 10% heat inactivated FBS (Atlas).
The following day, cells were co-transfected with 2 mg of the appropriate transfer vector, 1.5 mg of
the packaging plasmid psPAX2 (Addgene #12260), and 0.6 mg of the envelope plasmid (Addgene
#12259) with Lipofectamine 2000 (ThermoFisher) following manufacturer’s protocol. Harvest and
storage were performed as described above.
For knockdown experiments, lentivirus was titered by determining the number of antibiotic-resis-
tant colonies after puromycin treatment. For overexpression experiments, lentivirus was titered by
measuring integrated lentiviral copy number in host DNA with qRT-PCR as previously described
(Sastry et al., 2002). Control and tested groups were targeted at similar MOIs.
Lentivirus transduction
Cells were plated at 4500 cells/ cm2 for one day and then transduced with appropriate lentivirus in
expansion medium supplemented with 4 mg/mL polybrene (Sigma-Aldrich). Twenty-four hours post
transduction, cells were rinsed once in phosphate buffered saline (PBS). Cells were cultured with
fresh medium exchange every three days.
Cytotoxicity assay
Seven days post viral transduction, medium was collected and the amount of lactose dehydrogenase
(LDH) was measured as indirect output for cellular toxicity. Assays were performed following manu-
facturer’s protocol (Promega). Absorbance signal was recorded at 490 nm with the Cytation 5 instru-
ment (BioTek).
Huynh et al. eLife 2020;9:e49558. DOI: https://doi.org/10.7554/eLife.49558 15 of 25
Research article Stem Cells and Regenerative Medicine
RNA-seq library preparation
Isolated RNAs were stored at  80˚C and submitted to the Genome Technology Access Center at
Washington University in St Louis for library preparation and sequencing on a HiSeq 2500 (2  101
bp). Libraries were prepared using TruSeq Stranded Total RNA with Ribo-Zero Gold kit (Illumina).
RNA pull-down and mass spectrometry
The full sequence of GRASLND transcript variant 1 (RefSeq NR_033997.1) was synthesized by Inte-
grated DNA Technologies, Inc, and cloned into the pGEM-T Easy Vector System (Promega) using
the EcoRV site. This served as a template for subsequent in vitro transcription using the Riboprobe
Combination Systems Kit (Promega), with spiked-in biotin RNA labeling mix (Roche). Resulted bioti-
nylated sense and control antisense transcripts of GRASLND were stored at  80˚C until further proc-
essing. Cell lysates from day 21 pellets were homogenized in mRIPA buffer (Cell Signaling) and
centrifuged at 14,000 rpm for 15 min. The protein concentration of cell lysates was measured and
adjusted to 2 mg/mL. 500 mL of total protein (1 mg) were incubated with either 1.5 mg of GRASLND-
sense or -antisense RNA transcripts tagged with biotin-16-UTP overnight (12 hr). Following incuba-
tion, the RNA–protein mixtures and cell lysates (control) were incubated with 100 mL of prewashed
streptavidin beads for 3 hr at 4˚C (Pierce MS-Compatible Magnetic IP Kit, Streptavidin). The strepta-
vidin beads were then washed five times in 800 ml of ice cold PBS. Beads were eluted twice, each
with 30 mL of SDS elution buffer containing 100 mM Tris/HCl (pH 8), 4% SDS, and 50 mM DTT. The
elution was used either for mass spectroscopy (Proteomics Core Facility, Washington University
School of Medicine) or for Western blot (RayBiotech).
RNA immunoprecipitation (RIP)
Day 21 pellets were harvested and stored at  80˚C until further processing. Lysate was obtained by
homogenizing day 21 pellets in 1.1 mL of complete RIP lysis buffer (1X RIP lysis buffer, 200X prote-
ase inhibitor cocktail, 400X RNase inhibitor) (Millipore) with a bead beater (BioSpec Products) at
2500 oscillations per minute for 3 min for a total of five times. The lysate was subsequently trans-
ferred to a new microcentrifuge tube, incubated on ice for 5 min to allow for cell swelling by the
hypotonic RIP buffer, then stored at  80˚C overnight.
RIP assay was performed using the EZ-Magna RIP Kit (Millipore) with the rabbit anti-PKR (alias for
EIF2AK2) antibodies (Abcam) following manufacturer’s protocol. Separation of beads during the pro-
cedure was carried out using the MiniMACS separator (Miltenyi Biotec). Briefly, magnetic beads
were washed and prepared by incubating with 5 mg of rabbit anti-PKR antibodies or 5 mg of normal
rabbit IgG (negative control) per RIP reaction with rotation. Once the beads were ready, 900 mL of
fresh complete RIP immunoprecipitation buffer (1X RIP wash buffer, 0.5 M EDTA, 200X RNase inhibi-
tor) was added to the magnetic beads, followed by 100 mL of pellet lysate per reaction. Tubes were
incubated with rotation at 200 rpm overnight at 4˚C (Benchmark Orbi-Sharker Jr). The next day,
tubes were centrifuged briefly, and magnetic beads were washed with cold RIP wash buffer for a
total of six times. Proteins were subsequently degraded from resulting pull-down with proteinase K
(1X RIP wash buffer, 10% SDS, 8.3X proteinase K) at 55˚C for 30 min. After the incubation, tubes
were centrifuged briefly and beads were separated. Supernatant was transferred into a new micro-
centrifuge tube, to which 250 mL of buffer RL was added (Norgen Biotek). RNA was isolated as
described below using the Norgen Total RNA Isolation Plus Micro Kit (Norgen Biotek) following
the manufacturer’s protocol. An equal amount of eluted RNA was subsequently used for reverse
transcription, followed by qRT-PCR as described below.
Bulk RNA-seq analysis
Alignment and read assignment
Demultiplexed raw sequencing files were generated by the Genome Technology Access Center at
Washington University in St Louis. Reads were processed with trimmomatic-0.36 (Bolger et al.,
2014), aligned with STAR-2.6.0 (Dobin et al., 2013) and counted with featureCounts/Subread-
1.6.1 (Liao et al., 2014).
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Differential expression analysis
Downstream differential expression analysis was performed using DESeq2-1.16.1 (Love et al., 2014)
(abs[log2 fold change]>1 and adjusted p-values<0.05).
Gene ontology analysis
Gene ontology analysis of dysregulated genes was performed with enrichR-1.0 (Chen et al., 2013;
Kuleshov et al., 2016).
Transcription factor identification
Potential transcription factors were identified on the basis of the presence of annotated DNA-bind-
ing motifs with RcisTarget-1.0.2 (Aibar et al., 2017). Annotation databases for the motifs in human
transcription factors were previously compiled and can be downloaded at https://resources.aertslab.
org/cistarget/. Cis-BP motifs were ranked by normalized enrichment score (NES), and the top five
were reported in this paper.
Identification of lncRNA candidates
GSE109503 is the dataset that profiles transcriptomic changes of MSC chondrogenesis, composed
of six time points (day 0, day 1, day 3, day 7, day 14, and day 21) and three biological replicates.
Raw sequencing files were downloaded from the GEO Omnibus, and processed as described above.
Candidates were first restricted to those differentially expressed per day pair-wise (abs[log2 fold
change]>1 and adjusted p-values<0.05) and of detectable abundance (TPM >1 in more than six sam-
ples across the dataset). lncRNAs whose transcripts were not analyzed for transcript support level
(ENSEMBL TSL) were also excluded. For the surviving genes, Pearson correlation analysis was then
performed on mean expression per day. Candidates were identified as those with Pearson correla-
tion values >0.9 to all three investigated markers (ALCAM, VCAM1, ENG for MSC markers;
COL2A1, ACAN, COMP for chondrogenic markers; SOX5, SOX6, SOX9 for SOX transcription fac-
tors). GSE69110 depicts the transcriptomic changes of fibroblasts in response to SOX9 expression
levels (Supplementary file 1). Raw sequencing files were downloaded from the GEO Omnibus, and
processed similarly. Genes that were expressed differentially between two conditions (SOX9 overex-
pression versus GFP control) were then identified (abs[log2 fold change]>1 and adjusted p-val-
ues<0.1). The shortlist of lncRNAs are the intersecting candidates between genes emerging from
the above Pearson correlation analysis and dysregulated genes from this dataset.
Microarray analysis
Microarray processed data was downloaded from the GEO Omnibus and differential expression
analysis was performed with limma-3.34.6 (Ritchie et al., 2015).
Mass spectrometry analysis
Scaffold-4.8.4 (Proteome Software Inc) was used to validate MS/MS-based peptide and protein iden-
tifications. Peptide identifications were accepted if they could be established as having a greater
than 66.0% probability of achieving an FDR less than 1.0% by the Scaffold Local FDR algorithm. Pro-
tein identification was accepted if they could be established at a greater than 95.0% probability and
contained at least one identified peptide. Protein probabilities were assigned by the Protein
Prophet algorithm (Nesvizhskii et al., 2003). Proteins that contain similar peptides and could not be
differentiated on the basis of MS/MS analysis alone were grouped to satisfy the principles of parsi-
mony. To identify differentially bound proteins, one-tailed t-test was performed on sense samples
compared to naked beads, and sense samples were compared to antisense samples.
Chondrogenesis assay
MSCs or ASCs were digested in 0.05% trypsin-EDTA (Gibco), and trypsin was inactivated with 1.5X
volume of expansion medium. Dissociated cells were centrifuged at 200 x g for 5 min, and superna-
tant was aspirated. Subsequently, cells were washed in pre-warmed DMEM-high glucose (Gibco)
three times, and resuspended at 5  105 cells/mL in complete chondrogenic medium: DMEM-high
glucose (Gibco), 1% penicillin/streptomycin (Gibco), 1% ITS+ (Corning), 100 nM dexamethasone
(Sigma-Aldrich), 50 mg/mL ascorbic acid (Sigma-Aldrich), 40 mg/mL L-proline (Sigma-Aldrich), and 10
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ng/mL rhTGF-b3 (R and D Systems). 500 mL of the above cell mixture was dispensed into 15 mL coni-
cal tubes and centrifuged at 200 x g for 5 min. Pellets were cultured at 37˚C in 5% CO2 for 21 days
with medium exchange every three days.
Osteogenesis and adipogenesis assays
MSCs were plated at 2  104 cells/well in 6-well plates (Corning) and cultured for 4 days in MSC
expansion medium, followed by induction medium for 7 days. Osteogenic induction medium
includes: DMEM-high glucose (Gibco), 10% FBS, 1% penicillin/streptomycin (Gibco), 10 nM dexa-
methasone (Sigma-Aldrich), 50 mg/mL ascorbic acid (Sigma-Aldrich), 40 mg/mL L-proline (Sigma-
Aldrich), 10 mM b-glycerol phosphate (Chem-Impex International), and 100 ng/mL rh-BMP2 (Ther-
moFisher). Adipogenic induction medium includes: DMEM-high glucose (Gibco), 10% FBS (Thermo-
Fisher), 1% penicillin/streptomycin (Gibco), 1% ITS+ (Corning), 100 nM dexamethasone (Sigma-
Aldrich), 450 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich), and 200 mM indomethacin (Sigma-
Aldrich).
Biochemical assays
Harvested pellets were stored at  20˚C until further processing. Collected samples were digested in
125 mg/mL papain at 60˚C overnight. A DMMB assay was performed as previously described to mea-
sure GAG production (Farndale et al., 1986). PicoGreen assay (ThermoFisher) was performed to
measure DNA content following manufacture’s protocol.
Immunohistochemistry and histology
Harvested pellets were fixed in 4% paraformaldehyde for 48 hr, and processed for paraffin embed-
ding. Samples were sectioned at 10 mm thickness, and subjected to either Safranin O – Fast Green
standard staining (Estes et al., 2010) or to immunohistochemistry of collagen type II (Developmental
Studies Hybridoma Bank, University of Iowa). Human osteochondral sections were stained simulta-
neously to serve as a positive control. Sections with no primary antibodies were used as negative
control for immunohistochemistry.
Single-molecule RNA fluorescence in situ hybridization (RNA FISH)
Harvested pellets were snap frozen in Tissue-Plus O.C.T. Compound (Fisher HealthCare) and stored
at  80˚C until further processing. Samples were sectioned at 5 mm thickness and slides were stored
at  80˚C until staining. Probe sets for RNA FISH were conjugated with Quasar 670 dye and were
synthesized by LGC Biosearch Technologies to detect signal from a congregation of multiple probes
binding to target DNA. GAPDH probe set was pre-designed by the manufacturer. Probe sets are
listed in Figure 2—source data 2. Staining was carried out according to the manufacturer’s protocol
for frozen tissues. Slides were mounted with Prolong Gold anti-fade mountant with DAPI (Thermo-
Fisher) and imaged with the Virtual Slide Microscope VS120 (Olympus) at lower magnification. Con-
focal microscopy (Zeiss LSM 880) was used to capture images at higher magnification with the Plan-
Apochromat 63x/1.40 Oil DIC M27 objective. Fluorescence signal from target RNA FISH probes was
captured using a 633 nm excitation wavelength coupled with the Airyscan detector (Zeiss) to achieve
the best resolution with improved signal-to-noise ratio (Weisshart, 2014). Hoechst signal was cap-
tured on the PMT detector utilizing a 405 nm excitation wavelength.
RNA isolation and quantitative RT-PCR
Norgen Total RNA Isolation Plus Micro Kits (Norgen Biotek) were used to extract RNA from pellet
samples, and Norgen Total RNA Isolation Plus Kits (Norgen Biotek) were used for all other RNA iso-
lation. For monolayers, cells were lysed in buffer RL and stored at  20˚C until further processing. For
pellets, harvested samples were snap frozen in liquid nitrogen and stored at  80˚C until further
processing. On the day of RNA isolation, pellets were homogenized in buffer RL using a bead beater
(BioSpec Products) at 2500 oscillations per minute for 20 s for a total of three times. Subsequent
steps were performed following the manufacturer’s protocol.
Nuclear and cytoplasmic fractions from day 21 MSC pellets were separated with the NE-PER
Nuclear and Cytoplasmic Extraction Reagents (ThermoFisher) following the manufacturer’s protocol.
The resulting extracts were immediately subjected to RNA isolation using Norgen Total RNA
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Isolation Plus Micro Kits (Norgen Biotek) by adding 2.5 parts of buffer RL to 1 part of extract. Subse-
quent steps were carried out following the manufacturer’s protocol.
Reverse transcription by Superscript VILO cDNA master mix (Invitrogen) was performed immedi-
ately following RNA isolation. cDNA was stored at  20˚C until further processing. qRT-PCR was car-
ried out using Fast SyBR Green master mix (Applied Biosystems) following the manufacturer’s
protocol. A complete list of primer pairs (synthesized by Integrated DNA Technologies, Inc) is
reported in Figure 1—source data 2.
Luminescence assay
MSCs were plated at 8.5  104 cells per well in 24-well plates (Corning). Lentivirus carrying the
response elements for type I (ISRE) or type II (GAS) upstream of firefly luciferase was purchased from
Qiagen. 24 hours post plating, cells were co-transduced with virus in the following groups: ISRE with
scrambled shRNA, ISRE with GRASLND shRNA, GAS with scrambled shRNA, and GAS with
GRASLND shRNA. 24 hours post-transduction, cells were rinsed once in PBS and fresh medium was
exchanged. Three days later, medium was switched to expansion medium with 100 ng/mL IFN-b
(PeproTech) for wells with ISRE or with 5 ng/mL IFN-g (PeproTech) for wells with GAS. MSCs were
cultured for another 22 hr, and then harvested for luminescence assay using Bright-Glo Luciferase
Assay System (Promega). Luminescence signals were measured using the Cytation 5 Plate reader
(BioTek).
Western blot
On the day of harvest, cells were homogenized with complete lysis buffer in ice cold PBS: 10X RIPA
buffer (Cell Signaling Technology), 100X phosphatase inhibitor cocktail A (Santa Cruz Biotechnol-
ogy), and 100X Halt protease inhibitor cocktails (ThermoScientific). Lysates were subsequently centri-
fuged at 14,000 x g for 15 min at 4˚C, and supernatants were collected and stored at  20˚C until
further processing. Western blot was serviced by RayBiotech with the following antibodies: primary
anti-b-actin (RayBiotech), primary anti-RNF144A (Abcam), primary anti-PKR (alias anti-EIF2AK2) (Ray-
Biotech) and secondary anti-rabbit-HRP (horse radish peroxidase) (RayBiotech).
Statistical analyses
All statistical analyses were performed using R (R Development Core Team, 2018). Results from
biochemical assays are depicted as mean ± SD. Results from qRT-PCR are depicted as fold-change
with error bars calculated per Applied Biosystems manual instruction.
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Teboul L, Kent J, Joly JS, Concordet JP. 2016. Evaluation of off-target and on-target scoring algorithms and
integration into the guide RNA selection tool CRISPOR. Genome Biology 17:148. DOI: https://doi.org/10.
1186/s13059-016-1012-2, PMID: 27380939
Hagmann S, Moradi B, Frank S, Dreher T, Kämmerer PW, Richter W, Gotterbarm T. 2013. FGF-2 addition during
expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and
chondrogenic differentiation potential. Cell Proliferation 46:396–407. DOI: https://doi.org/10.1111/cpr.12046,
PMID: 23869761
Harrop AR, Ghahary A, Scott PG, Forsyth N, Uji-Friedland A, Tredget EE. 1995. Regulation of collagen synthesis
and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. Journal of
Surgical Research 58:471–477. DOI: https://doi.org/10.1006/jsre.1995.1074, PMID: 7745958
Hertzog PJ, Hwang SY, Kola I. 1994. Role of interferons in the regulation of cell proliferation, differentiation, and
development. Molecular Reproduction and Development 39:226–232. DOI: https://doi.org/10.1002/mrd.
1080390216, PMID: 7530016
Hu X, Ivashkiv LB. 2009. Cross-regulation of signaling pathways by interferon-gamma: implications for immune
responses and autoimmune diseases. Immunity 31:539–550. DOI: https://doi.org/10.1016/j.immuni.2009.09.
002, PMID: 19833085
Huynh NP, Anderson BA, Guilak F, McAlinden A. 2017. Emerging roles for long noncoding RNAs in skeletal
biology and disease. Connective Tissue Research 58:116–141. DOI: https://doi.org/10.1080/03008207.2016.
1194406, PMID: 27254479
Huynh NPT, Brunger JM, Gloss CC, Moutos FT, Gersbach CA, Guilak F. 2018a. Genetic engineering of
mesenchymal stem cells for differential matrix deposition on 3D woven scaffolds. Tissue Engineering Part A 24:
1531–1544. DOI: https://doi.org/10.1089/ten.tea.2017.0510, PMID: 29756533
Huynh NPT, Zhang B, Guilak F. 2018b. High-depth transcriptomic profiling reveals the temporal gene signature
of human mesenchymal stem cells during chondrogenesis. The FASEB Journal 33:358–372. DOI: https://doi.
org/10.1096/fj.201800534R, PMID: 29985644
Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N. 2004. The essential involvement of cross-talk between IFN-
gamma and TGF-beta in the skin wound-healing process. The Journal of Immunology 172:1848–1855.
DOI: https://doi.org/10.4049/jimmunol.172.3.1848, PMID: 14734769
Jang YN, Baik EJ. 2013. JAK-STAT pathway and myogenic differentiation. Jak-Stat 2:e23282. DOI: https://doi.
org/10.4161/jkst.23282, PMID: 24058805
Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. 1998. In vitro chondrogenesis of bone marrow-
derived mesenchymal progenitor cells. Experimental Cell Research 238:265–272. DOI: https://doi.org/10.1006/
excr.1997.3858, PMID: 9457080
Kabadi AM, Ousterout DG, Hilton IB, Gersbach CA. 2014. Multiplex CRISPR/Cas9-based genome engineering
from a single lentiviral vector. Nucleic Acids Research 42:e147. DOI: https://doi.org/10.1093/nar/gku749,
PMID: 25122746
Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawelec G. 1992. Determination of cytokines in synovial fluids:
correlation with diagnosis and histomorphological characteristics of synovial tissue. Annals of the Rheumatic
Diseases 51:731–734. DOI: https://doi.org/10.1136/ard.51.6.731, PMID: 1616355
Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome
browser at UCSC. Genome Research 12:996–1006. DOI: https://doi.org/10.1101/gr.229102, PMID: 12045153
Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM,
Lachmann A, McDermott MG, Monteiro CD, Gundersen GW, Ma’ayan A. , 2016. Enrichr: a comprehensive
gene set enrichment analysis web server 2016 update. Nucleic Acids Research 44:W90–W97. DOI: https://doi.
org/10.1093/nar/gkw377, PMID: 27141961
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W,
Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, et al.
2001. Initial sequencing and analysis of the human genome. Nature 409:860–921. DOI: https://doi.org/10.
1038/35057062, PMID: 11237011
Lee JT, Bartolomei MS. 2013. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell
152:1308–1323. DOI: https://doi.org/10.1016/j.cell.2013.02.016, PMID: 23498939
Li J. 2013. JAK-STAT and bone metabolism. Jak-Stat 2:e23930. DOI: https://doi.org/10.4161/jkst.23930
Liao Y, Smyth GK, Shi W. 2014. featureCounts: an efficient general purpose program for assigning sequence
reads to genomic features. Bioinformatics 30:923–930. DOI: https://doi.org/10.1093/bioinformatics/btt656,
PMID: 24227677
Huynh et al. eLife 2020;9:e49558. DOI: https://doi.org/10.7554/eLife.49558 23 of 25
Research article Stem Cells and Regenerative Medicine
Liu SJ, Horlbeck MA, Cho SW, Birk HS, Malatesta M, He D, Attenello FJ, Villalta JE, Cho MY, Chen Y, Mandegar
MA, Olvera MP, Gilbert LA, Conklin BR, Chang HY, Weissman JS, Lim DA. 2017. CRISPRi-based genome-scale
identification of functional long noncoding RNA loci in human cells. Science 355:eaah7111. DOI: https://doi.
org/10.1126/science.aah7111
Londhe P, Davie JK. 2011. Gamma interferon modulates myogenesis through the major histocompatibility
complex class II transactivator, CIITA. Molecular and Cellular Biology 31:2854–2866. DOI: https://doi.org/10.
1128/MCB.05397-11, PMID: 21576360
Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biology 15:550. DOI: https://doi.org/10.1186/s13059-014-0550-8, PMID: 25516281
Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. 1998. Chondrogenic differentiation
of cultured human mesenchymal stem cells from marrow. Tissue Engineering 4:415–428. DOI: https://doi.org/
10.1089/ten.1998.4.415
Mayo CB, Cole JL. 2017. Interaction of PKR with single-stranded RNA. Scientific Reports 7:3335. DOI: https://
doi.org/10.1038/s41598-017-03047-7, PMID: 28611419
Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK,
Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE.
2006. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell
124:1283–1298. DOI: https://doi.org/10.1016/j.cell.2006.01.040, PMID: 16564017
Nallagatla SR, Hwang J, Toroney R, Zheng X, Cameron CE, Bevilacqua PC. 2007. 5’-triphosphate-dependent
activation of PKR by RNAs with short stem-loops. Science 318:1455–1458. DOI: https://doi.org/10.1126/
science.1147347, PMID: 18048689
Necsulea A, Soumillon M, Warnefors M, Liechti A, Daish T, Zeller U, Baker JC, Grützner F, Kaessmann H. 2014.
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